Work

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort

Year: 2018

Type: article

Study design: Observational Study

Abstract: In lymphangioleiomyomatosis patients receiving sirolimus treatment, transient leukopenia in the morning may be due to circadian rhythm, with leukocyte counts recovering later in the day, indicating that a decrease in drug dose may not be warrantedhttp://ow.ly/jPFz30iysgV

Source: ERJ Open Research

DOI: 10.1183/23120541.00121-2017

Authors: Vissagan Gopalakrishnan, Amanda M. Jones, Patricia Julien-Williams, Tania Machado, Robert L. Danner, Jeffrey J. Swigris, Robert Paine, Jay N. Lozier, Joel Moss

Institutions: Rush University Medical Center, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institutes of Health Clinical Center, National Jewish Health, University of Utah, University of Utah Health Care

Language: English

Topic: Tuberous Sclerosis Complex Research

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $808

Funders: Tuberous Sclerosis Alliance, LAM Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Clinical Center

Award: G7183727877

OpenAlex ID: W2792331104

FWCI: 0.344

Cites: 21

Cited by: 2

Related to: 10